Category:
Business
The radiofrequency (RF) ablation devices market stood at $3,173.5 million in 2019, and it is projected to reach $11,080.3 million by 2030, exhibiting a 12.6% CAGR during the forecast period (2020–2030). This growth can be attributed to the improving healthcare infrastructure, surging cases of chronic disorders, technological developments, and booming geriatric population. Such devices use RF energy to destroy diseased tissue, such as tumors and arteriovenous malformations (AVMs), offering a shorter, less-painful, and less-invasive treatment option than conventional open surgeries.



